Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous

Last updated: June 24, 2021
Sponsor: North Estonia Medical Centre
Overall Status: Active - Recruiting

Phase

N/A

Condition

Soft Tissue Infections

Intra-abdominal Infections

Appendicitis

Treatment

N/A

Clinical Study ID

NCT04947748
1
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated appendicitis.

Eligibility Criteria

Inclusion

Inclusion Criteria: Patients diagnosed with acute appendicitis and are candidates for laparoscopicappendectomy.

Exclusion

Exclusion Criteria: Patients with compromised immune system (HIV, diabetes), ongoing or completedradio-chemotherapy in past 5 years, prosthetic heart valve, vascular prosthesis, pregnancy.

Study Design

Total Participants: 100
Study Start date:
November 01, 2020
Estimated Completion Date:
December 31, 2021

Connect with a study center

  • North Estonia Medical Centre

    Tallin,
    Estonia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.